See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.97▲ 1.51%
← NPK page
XStocksXray
Market X-Ray report · 22 October 2026

Nampak (NPK)

Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026

Key indicators

Last closeZAC 51,050.00
52-week range42,000.00 – 57,000.00
Return, 1 month / 3 months+11.0% / +18.7%
Return, 1 year / 3 years+12.8% / +159.3%
TrendUptrend
RSI (14)69
Volatility (1 year)25.5%
Worst drawdown (1 year)-22.9%
Average daily value traded248.87M ZAC
Dividend yield–

Market X-Ray price-based

66/ 100 · High confidence · ahead of 75% of stocks on this exchange
Trend70
Momentum69
Stability (higher is calmer)67
Liquidity48
Income–

Five-year price chart navy: price · brown: 200-day average

7,71926,55945,39864,23783,0762021-102023-012024-042025-072026-10

About the company

Nampak is a packaging company based in South Africa. It makes metal, glass and plastic containers as well as paper and board packaging, serving customers in food, beverage, healthcare and other consumer markets. Its products include cans, bottles, closures, cartons and labels used by manufacturers and retailers. The company operates manufacturing sites in several African countries and supplies packaging for everyday consumer goods.

On this site Nampak appears as a stock on the Johannesburg Exchange (South Africa), code NPK, with prices in South African cents (ZAC). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Nampak (NPK) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 51,050.00 on 22 October 2026.

Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 60 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 12.8% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Nampak (NPK)

The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange

Lens and metricValueScoreReading
Trend70 · StrongTrading above its long-term averages and near its highs.
Above 200-day average7.9%
From 52-week high-8.0%
Momentum69 · FairTypical recent returns for this exchange.
3-month return18.7%
6-month return4.6%
12-month return, skipping the last month1.7%
Stability (higher is calmer)67 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)25.5%
Worst drawdown, 1 year (smaller is calmer)-22.9%
Liquidity48 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded248.87M ZAC
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+0.1%
1 month+11.0%
3 months+18.7%
6 months+4.6%
1 year+12.8%
3 years+159.3%
5 years−23.7%

Signals

50-day / 200-day average46,853.58 / 47,322.25
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1,215.90

Technical summary

DailyStrongly bullish12 bullish · 2 neutral · 2 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 23 Oct 2026